News room

Egetis is an innovative, unique, and integrated pharmaceutical drug development company, focusing on projects in late-stage development for treatment of serious rare/niche diseases with significant unmet medical needs in the orphan drug segment

Media contact

 

Karl Hård, VP Investor Relations & Business Development

[email protected]

Calendar and upcoming reports

September 16, 2026
Morgan Stanley 24th Annual Global Healthcare Conference

November 6, 2026 (7:00am CET)
Interim Report Q3 2026

Show more events

Share

Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10

E-mail: [email protected]